And not every Wall Street strategist is panicking. The biggest bull remains Oppenheimer’s John Stoltzfus, who reiterates his 7,100 year-end call for the S&P 500. Now alone for second-highest target is ...
Expedia Group (NASDAQ:EXPE – Free Report) had its price objective trimmed by Oppenheimer from $235.00 to $230.00 in a ...
Such an advance, leaders agree, would fundamentally transform society. Google CEO Sundar Pichai has repeatedly described AI ...
Shares of Nektar Therapeutics (NASDAQ:NKTR) added ~9% in the premarket on Friday after Oppenheimer upgraded the biopharma to ...
Fueled by DOGE’s tactics, many car buyers -- particularly those who identify as liberal or connected with the Democratic Party, the opposition to Trump’s Republicans -- appear to have begun ratcheting ...
(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...
Netflix’s CCO Bela Bajaria believes Oppenheimer would have thrived on streaming. But would it really match its box office ...
Oppenheimer Asset Management pointed out that the S&P 500 (SP500) has dipped down to test its 200-day moving average ...
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) was upgraded by equities research analysts at Oppenheimer from a “market ...
Remembering Pat, a good friend from Omaha, Neb.
Managing Director - Investments CFP The Summa Group of Oppenheimer & Co. Inc. Asset/Investment Management ...
Director Christopher Nolan's The Odyssey, is gearing up to be his biggest blockbuster yet, as there are many exciting facts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results